This inventor holds 1 USPTO granted patent. Top assignees: Kansai Medical University, Zeria Pharmaceutical Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 11 
1 out of 45 Years Active: 2008
Title: Yoshiya Tahashi: Innovator in Antibody Research
Introduction
Yoshiya Tahashi is a notable inventor based in Suita, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Yoshiya Tahashi holds a patent for "Antibodies specific for phosphorylation sites and screening methods using the same antibodies." This includes a polyclonal antibody that is specific for a phosphorylated linker region in Smad2 and/or Smad3. This invention is crucial for advancing research in cellular signaling and disease mechanisms.
Career Highlights
Throughout his career, Yoshiya has worked with prominent organizations, including Zeria Pharmaceutical Co., Ltd. and Kansai Medical University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Yoshiya has collaborated with notable colleagues such as Koichi Matsuzaki and Toshihito Seki. These partnerships have enhanced his research capabilities and fostered innovation in antibody development.
Conclusion
Yoshiya Tahashi's contributions to antibody research exemplify the vital role of inventors in advancing medical science. His innovative work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile